Federated Hermes’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,232,546
| Closed | -$47.4M | – | 2260 |
|
|
2023
Q2 | $47.4M | Sell |
1,232,546
-19,842
| -2% | -$762K | 0.12% | 217 |
|
|
2023
Q1 | $29M | Buy |
1,252,388
+363,934
| +41% | +$8.43M | 0.07% | 305 |
|
|
2022
Q4 | $23.3M | Buy |
888,454
+750,191
| +543% | +$19.7M | 0.06% | 346 |
|
|
2022
Q3 | $2.72M | Buy |
+138,263
| New | +$2.72M | 0.01% | 827 |
|
|
2021
Q2 | – | Sell |
-18,099
| Closed | -$282K | – | 2367 |
|
|
2021
Q1 | $282K | Buy |
18,099
+16,378
| +952% | +$255K | ﹤0.01% | 1653 |
|
|
2020
Q4 | $27K | Buy |
+1,721
| New | +$27K | ﹤0.01% | 1888 |
|
|
2020
Q2 | – | Sell |
-123
| Closed | -$2K | – | 2409 |
|
|
2020
Q1 | $2K | Buy |
+123
| New | +$2K | ﹤0.01% | 2052 |
|
|
2018
Q4 | – | Sell |
-2,066
| Closed | -$76K | – | 2347 |
|
|
2018
Q3 | $76K | Buy |
2,066
+1,505
| +268% | +$55.4K | ﹤0.01% | 1695 |
|
|
2018
Q2 | $20K | Buy |
561
+75
| +15% | +$2.67K | ﹤0.01% | 1799 |
|
|
2018
Q1 | $23K | Buy |
486
+25
| +5% | +$1.18K | ﹤0.01% | 1740 |
|
|
2017
Q4 | $17K | Buy |
461
+69
| +18% | +$2.54K | ﹤0.01% | 1801 |
|
|
2017
Q3 | $21K | Buy |
392
+41
| +12% | +$2.2K | ﹤0.01% | 1748 |
|
|
2017
Q2 | $20K | Buy |
351
+40
| +13% | +$2.28K | ﹤0.01% | 1758 |
|
|
2017
Q1 | $17K | Buy |
+311
| New | +$17K | ﹤0.01% | 1752 |
|